Atıf İçin Kopyala
Youngstein T., Hoffmann P., Gül A., Lane T., Williams R., Rowczenio D. M. , ...Daha Fazla
RHEUMATOLOGY, cilt.56, ss.2102-2108, 2017 (SCI İndekslerine Giren Dergi)
Objective. To provide outcome data concerning pregnancies exposed to the Interleukin-1 (IL-1) inhibitors prior to conception in both men and women, during pregnancy and breast feeding.